By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Akebia Therapeutics, Inc. 

9987 Carver Road
Suite 420
Cincinnati  Ohio  45242  U.S.A.
Phone: 513-618-0931 Fax: 513-618-0950


SEARCH JOBS








Company News
Akebia Therapeutics, Inc. (AKBA) Prices Public Offering Of Common Stock 4/17/2015 11:25:00 AM
Akebia Therapeutics, Inc. (AKBA) Announces Proposed Public Offering Of Common Stock 4/15/2015 12:38:38 PM
Akebia Therapeutics, Inc. (AKBA) Announces Presentation Of Results From Its Phase IIb Study Of AKB-6548 In Non-Dialysis Patients With Anemia Related To Chronic Kidney Disease At International Society of Nephrology’s World Congress Of Nephrology 3/16/2015 11:01:49 AM
Akebia Therapeutics, Inc. (AKBA) To Host Conference Call And Slide Webcast Following Presentation Of AKB-6548 Phase 2b Study Results At International Society of Nephrology’s World Congress Of Nephrology 3/11/2015 10:25:07 AM
Akebia Therapeutics, Inc. (AKBA) Announces Completion Of Enrollment In Phase 2 Trial Of AKB-6548 In Dialysis Patients With Anemia Related To Chronic Kidney Disease 3/10/2015 11:34:17 AM
Akebia Therapeutics, Inc. (AKBA) To Present At The 27th Annual ROTH Conference 3/5/2015 11:10:23 AM
Akebia Therapeutics, Inc. (AKBA) Announces Fourth Quarter And Full-Year 2014 Financial Results 3/4/2015 11:20:45 AM
Akebia Therapeutics, Inc. (AKBA) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/3/2015 12:14:38 PM
Akebia Therapeutics, Inc. (AKBA) Completes Enrollment In The Two Planned Cohorts Of Its Phase 2 Study Of AKB-6548 In Patients With Anemia Related To Chronic Kidney Disease Undergoing Dialysis 1/6/2015 9:39:51 AM
Akebia Therapeutics, Inc. (AKBA) Added To NASDAQ Biotechnology Index 12/15/2014 11:40:18 AM
123456
//-->